Müller-Bruhn, Ronja (Stimit AG 202104 CEO + Founder) |
Chief Executive Officer (CEO) |
Dräger (Group) |
Switzerland |
Müller-Fahrnow, Anke (Bayer 201211 VP + Head Lead Discovery Berlin at Bayer HealthCare Global Drug Discovery) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
Müller-Hartmann, Herbert A. (Ningaloo Biosytems 202006– Managing Director + Co-Founder) |
Managing Director |
Ningaloo Biosystems GmbH |
Germany |
Müller-Kirschbaum, Thomas (Henkel 201306 SVP R&D + Supply Chain Laundry & Home Care) |
President/Director/Head Business Group/Unit/Division |
Henkel (Group) |
Germany |
Müller-Kuhrt, Lutz (AnalytiCon Discovery 200503 CEO) |
Managing Director |
BRAIN (Group) |
Germany |
Müller-Röber, Bernd (MPI + Univ Potsdam 201002 + Member BioÖkonomieRat) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
Müller-Späth, Reinhard (P.A.L.M. 200412 CEO) |
Chief Executive Officer (CEO) |
Carl Zeiss (Group) |
Germany |
Müller-Veith, Werner (Ametek 201807 Managing Director of Grabner Instruments) |
Managing Director |
AMETEK (Group) |
Austria |
Müller. Franz (Methrom –201212 Managing Director of Deutsche Methrom Prozessanalytik GmbH & Co KG RETIRED 12/12) |
Managing Director |
Metrohm (Group) |
Germany |
Müllershausen, Florian (Novartis 201808 at Novartis Venture Fund) |
n. a. |
Novartis (Group) |
Switzerland |
Mynar, Justin L. (KAUST 201803 Asscoc VP for Research + Executive Director of Core Labs) |
Laboratory Manager (university / research institute) |
King Abdullah University of Science and Technology (KAUST) |
Saudi Arabia |
Münch, Götz (Corimmmun 200701 Managing Director + Co-founder before Procorde) |
Managing Director |
Johnson & Johnson (JnJ) (Group) |
Germany |
Münchbach, Martin (Bellevue 201904 Managing Partner at BB Pureos Bioventures) |
Managing Partner (investment firm) |
Bellevue (Group) |
United Kingdom (GB) |
Münchmeyer, Wolf-Eckart (Airsense Analytics 200911 Managing Director + Photonion 200911 Managing Director) |
Managing Director |
Airsense Analytics GmbH |
Germany |
Münker, Michael (Photonics Healthcare 201310 Manaing Director + Co-founder) |
Managing Director |
Photonics Healthcare (Group) |
Netherlands |
Münster, Helmut (MasCom 201007– Managing Director before Thermo Fisher Product Manager Bremen) |
Managing Director |
MasCom Analysengeräte Service GmbH |
Germany |
Münzing, Mike (Münsingen (govt) 201111 Mayor) |
Mayor |
Münsingen (govt city) |
Germany |
Mädler, Kathrin (Univ Bremen 201201 Professor) |
Professor |
University of Bremen |
Germany |
Mähler, Solveigh Karola (MC Services 201312– Life Sciences Team before Qiagen Director IR/PR before WestLB) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
Märk, Lukas (Ionicon 201106– CEO before Marketing + Sales joined 2005) |
Chief Executive Officer (CEO) |
Ionicon (Group) |
Austria |
Märk, Tilmann (1998– Prof Univ Innsbruck + Co-founder + 2001–201105 CEO Ionicon Analytik GmbH) |
Chief Executive Officer (CEO) |
Ionicon (Group) |
Austria |
Märki, Iwan (Abionic 201909 CTO) |
Chief Technology/Technical Officer (CTO) |
Abionic S.A. |
Switzerland |
Märzendorfer, Walter (Siemens 200909 Siemens Healthcare Head Magnetic Resonance) |
n. a. |
Siemens (Group) |
Germany |
Märzhäuser, Günter (Märzhäuser 201608 Managing Director at Märzhäuser Wetzlar GmbH & Co KG) |
Managing Director |
Märzhäuser (Group) |
Germany |
Märzhäuser, Stephan (Märzhäuser 201608 Managing Director at Märzhäuser Wetzlar GmbH & Co KG) |
Managing Director |
Märzhäuser (Group) |
Germany |
Mätzig, Christoph (AMETEK 201610– Managing Director at Spectro before Leica Microsystems + Heraeus + Balzer Process) |
Managing Director |
AMETEK (Group) |
Germany |
Mätzold, Andreas (BBB Management GmbH Campus Berlin-Buch 201104 Managing Director) |
Managing Director |
Campus Berlin-Buch GmbH |
Germany |
Möhler, Hanns |
n. a. |
University of Zurich (UZH) |
Switzerland |
Mölders, Monika (Roche 201308 Roche Diagnostics GmbH) |
n. a. |
Roche (Group) |
Germany |
Möller, Andreas (Multi Channel Systems MCS Founder) |
Company Founder |
Harvard Bioscience (Group) |
Germany |
Möller, Gerald (HBM Bio Ventures 201007 Advisor former Roche + Boehringer Mannheim CEO 1995–1997) |
Board member, non-executive |
HBM (Group) |
Germany |
Möller, Jörg (Bayer 201403–202012 Bayer HealthCare Head of Global Development LEFT 12/20) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
Möller, Jörn (MYR GmbH 201012– Managing Director) |
Managing Director |
Gilead Sciences (Group) |
Germany |
Möller, Thomas (BioMedPartners 201702 General Partner) |
General Partner (venture partner) |
BioMedPartners (Group) |
Switzerland |
Möller, Thomas (Merck (DE) 201701– Head of External Communications before BASF) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
Möller, Uwe (emp Biotech 201202 Managing Director) |
Managing Director |
emp Biotech GmbH |
Germany |
Möllerbernd, Norbert (Bremen (govt) 201111 WFB Innovationsmanager) |
Administrative Officer (personnel) |
Bremen (govt region) |
Germany |
Møller, Claus (Azanta 201206 CEO) |
Chief Executive Officer (CEO) |
Azanta (Group) |
Denmark |
Nachtigal, Dirk (BASF 201109 Managing Director of BASF Venture Capital GmbH) |
Managing Director |
BASF (Group) |
Germany |
Nachtigall, Dieter (Quantro Therapeutics 202007 CEO before Boehringer Ingelheim) |
Chief Executive Officer (CEO) |
Quantro Therapeutics GmbH |
Austria |
Nacke, Raoul (Eric Salmon & Partners 201305 Head of German business) |
n. a. |
Eric Salmon & Partners (Group) |
Germany |
Nadella, Satya (Microsoft 201910 CEO) |
Chief Executive Officer (CEO) |
Microsoft (Group) |
United States (USA) |
Naef, Francois (Merck (DE) –201312 LEFT Merck 12/13) |
General Counsel / Chief Legal Officer (CLO) |
Merck (DE) (Group) |
Germany |
Nafe, Christian (Coral BioNet 201102– promoted CEO Scil Technology GmbH before CFO joined Scil 4/00) |
Chief Executive Officer (CEO) |
Coral BioNet (Group) |
Germany |
Nagel, Christian (Earlybird 201807 Managing Director) |
Managing Director |
Earlybird (Group) |
Germany |
Nagel, Ralf (Bremen (govt) 200906 Senator für Wirtschaft + Häfen RESIGNED) |
Minister |
Bremen (govt region) |
Germany |
Nagel, Roman |
n. a. |
ING (Group) |
Germany |
Naggert, Michael (Seleckt-ID Biolabs GmbH 201502 Managing Director) |
Managing Director |
selekt-ID Biolabs GmbH |
Germany |
Nagler, Peter (Evonik 201201 Chief Innovation Officer) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evonik (Group) |
Germany |
Nagy, Andras (Univ Toronto 202004 Professor at Samuel Lunenfeld Research Institute of Mount Sinai Hospital) |
President/Director/Head Business Group/Unit/Division |
University of Toronto |
Canada |
Nagy, Elisabeth (Univ Szeged 201203 Prof Dept of Clinical Microbiology) |
Professor |
University of Szeged |
Hungary |
Nagy, Eszter (Arsanis 201010– CSO + Co-founder before SVP Research at Intercell AG) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Arsanis (Group) |
Austria |
Nahas, Nasri G. (Spinomix 201506 CEO before GeneBio CEO) |
Chief Executive Officer (CEO) |
Spinomix S.A. |
Switzerland |
Nahavandi, Ali (Alna-Bioscience 201012 Managing Director + Founder) |
Managing Director |
Alna-Biscience GmbH & Co. KG |
Germany |
Naheta, Akshay (SoftBank 201708 Managing Director of SoftBank Group International) |
Chief Executive Officer (CEO) |
SoftBank (Group) |
|
Nakamoto, Akira (Shimadzu 201504– Board Chairma before CEO) |
Board member, non-executive |
Shimadzu (Group) |
Japan |
Nakamura, Koji (Chiome Bioscience 201710 Head Drug Discovery Labs before CEO of LivTech) |
Research & Development Manager |
Chiome Bioscience (Group) |
Japan |
Nakaya, Kazuya (Panasonic 201206 Executive Managing Director of Panasonic Healthcare Co., Ltd.) |
Managing Director |
PHC (Group) |
Japan |
Nakayama, Joji (Daiichi Sankyo 201512 CEO) |
Chief Executive Officer (CEO) |
Daiichi Sankyo (Group) |
Japan |
Nam, Kiyean (Qurient (KR) 201506 CEO) |
Chief Executive Officer (CEO) |
Qurient Co., Ltd. (KRX 115180) |
Korea, Republic of |
Naményi, Christof (AXA 201208 Managing Director of AXA Private Equity) |
Managing Director |
Ardian (Group) |
France |
Namouni, Fouad (BMS 201706 Head of Development Oncology) |
President/Director/Head Business Group/Unit/Division |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
Naraghi, Mohammad (Siemens Medical Solutions 200603 Head of Business Development) |
Business Development Manager / Strategy Manager |
Siemens (Group) |
Germany |
Narasimhan, Vasant (Vas) (Novartis 201408– Global Head Developm Novartis Pharma before Global Head Developm Vaccines |
Research & Development Manager |
Novartis (Group) |
United States (USA) |
Narayanan, Sabrina (Biofrontera 200801– Media-Scientific Expert before Galderma) |
n. a. |
Biofrontera (Group) |
Germany |
Nash, Andrew (Zenyth 200602 CEO) |
Chief Executive Officer (CEO) |
CSL (Group) |
Australia |
Nastos, Aristotelis (Creathor Ventures 201604 before NRW.Bank + Peppermint.) |
Investment Manager |
Creathor Ventures (Group) |
Germany |
Natanek, Rafael (Gilde Investment 201903c– Partner at Gilde Healthcare before Bain Consulting) |
Partner (venture partner) |
Gilde Investment (Group) |
Netherlands |
Nathrath, Daniel (Ada Health 201712 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Ada Health (Group) |
Germany |
Natsias, Konstantinos (CAMAG 201302 CEO) |
Chief Executive Officer (CEO) |
CAMAG (Group) |
Switzerland |
Nauck, Matthias (Univ Greifswald 201606 Professor + Baltic Analytics GmbH 201112 Managing Director) |
Managing Director |
Baltic Analytics GmbH |
Germany |
Navabi, Stefanie (Biometra 200710) |
n. a. |
Endress+Hauser (Group) |
Germany |
Naval, Jordi (Biocat 202003 CEO) |
Chief Executive Officer (CEO) |
Biocat (BioRegion of Catalonia Private Foundation / Fundació Privada BioRegió de Catalunya) |
Spain (España) |
Navid, Sasan (Virometix 202007 CFO before Amgen + Ernst & Young) |
Chief Financial Officer (CFO) |
Virometix AG |
|
Navon, Benjamin (W2O Group 201807) |
Public Relations Manager / Investor Relations Manager |
W2O Group (Group) |
United States (USA) |
Navot, Nir (Pronto Diagnostics 201010 CEO) |
Chief Executive Officer (CEO) |
Pronto Diagnostics Ltd. |
Israel |
Nawana, Namal (Alere 201602 CEO) |
Chief Executive Officer (CEO) |
Alere (Group) |
United States (USA) |
Nazabal, Alexis (CovalX 200902 CEO) |
Chief Executive Officer (CEO) |
CovalX (Group) |
Switzerland |
Neal, Rodney (Körber 201703– VP Strategic Program Management at Werum IT Solutions America) |
Sales Manager / Marketing Manager |
Körber (Group) |
Germany |
Nebel, Simon (Aravis 201401– Managing Partner + Founder) |
Managing Partner (investment firm) |
Aravis (Group) |
Switzerland |
Nechansky, Andreas (Vela Laboratories 201107 COO) |
Chief Operating Officer (COO) |
Vela pharmazeutische Entwicklung und Laboranalytik GmbH (Vela Laboratories) |
Austria |
Nederkoorn, Paul H. J. (Ostendum R&D BV 201401 CEO) |
Chief Executive Officer (CEO) |
Ostendum R&D B.V. |
Netherlands |
Neeleman, Christiaan (Definiens 201309– COO before among others Philips Healthcare) |
Chief Operating Officer (COO) |
AstraZeneca (Group) |
Germany |
Neermann, Jörg (200701– Life Sciences Partners also Kaneas Capital founder before DVC before Atlas Venture) |
Investment Manager |
Life Sciences Partners (LSP) |
Germany |
Nehls, Michael C. (Ingenium 200604 CEO) |
Chief Executive Officer (CEO) |
Vivoryon (Group) |
Germany |
Nehrbass, Ulf (Ksilink 201709 CEO before QurlentTherapeutics + Institut Pasteur Korea + Institut Pasteur Paris) |
Chief Executive Officer (CEO) |
Ksilink (FR) |
France |
Neil, Madeleine (Uppsala BIO 201109 Director of Communications) |
Public Relations Manager / Investor Relations Manager |
Uppsala BIO |
Sweden |
Neirinck, Dirk (Endress+Hauser 201510 Managing Director of Endress+Hauser Consult AG) |
Managing Director |
Endress+Hauser (Group) |
Switzerland |
Neiss, Ursula |
n. a. |
Roche (Group) |
Germany |
Nell, Peter (Mammoth Biosciences 202001c– CBO before Co-Founder of Casebia) |
Chief Business Officer (CBO) |
Mammoth Biosciences Inc. |
United States (USA) |
Nelson, Todd R. (eBioscience 200708– CEO before Invitrogen + RBC Capital Markets + Merrill Lynch) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
United States (USA) |
Nemeth, Balazs (IMMS GmbH 201406 Manager Bioanalytical + Biomedical Sensors) |
Researcher (university / research institute) |
Institut für Mikroelektronik- und Mechatronik-Systeme gGmbH (IMMS) |
Germany |
Nerger, Matthias (Nordrhein-Westfalen (govt) 2008–201204 Head of BIO.NRW Office LEFT 4/12) |
Cluster Manager |
Nordrhein-Westfalen (govt region) |
Germany |
Neri, Duccio (Philogen 201301 CEO) |
Chief Executive Officer (CEO) |
Philogen (Group) |
Italy |
Nesmith, Ken (Lexent Bio 202006 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Nessi, Claudio (NeoMed Management 201309) |
Investment Manager |
NeoMed (Group) |
United Kingdom (GB) |
Nestler, Klaus (Corporate Finance Partners 201402 Managing Director at CFP BioConnect AG) |
Managing Director |
Corporate Finance Partners (CFP) (Group) |
Germany |
Nestmann, Judith (Bayer 201507 Investor Relations Manager) |
Public Relations Manager / Investor Relations Manager |
Bayer (Group) |
Germany |
Nestorov, Peter (Scailyte 201901 CEO) |
Chief Executive Officer (CEO) |
Scailyte AG |
Switzerland |
Nettersheim, Michael (202009 ECBF General Partner before HTGF 200912 Investment Manager before MediGene AG) |
General Partner (venture partner) |
European Circular Bioeconomy Fund (ECBF) |
Germany |